NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
May 25, 2021 08:00 ET
|
NeuBase Therapeutics, Inc.
PITTSBURGH, May 25, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotechnology company accelerating the genetic revolution using a new class of...
ActivX Biosciences reports key findings that could impact the use of clinically approved CDK4/6 inhibitors in the treatment of cancer patients
March 11, 2019 10:00 ET
|
ActivX Biosciences
LA JOLLA, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces a report published in a high profile,...
ActivX Biosciences’ KiNativ® platform featured in two articles demonstrating the importance of native kinase profiling for characterizing protein degraders
January 19, 2018 10:00 ET
|
ActivX Biosciences
LA JOLLA, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces two reports published in high profile,...
ActivX Biosciences, Inc. Appoints Hugh Rosen Chairman & President; John Kozarich Transitions to New Role
February 22, 2017 12:00 ET
|
ActivX Biosciences
LA JOLLA, Calif., Feb. 22, 2017 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc.®, a wholly owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces the appointment of Professor Hugh Rosen...
ActivX Biosciences Publishes Two Key Articles Demonstrating Breadth of Applications for KiNativ(R) Technology in Drug Discovery
October 20, 2016 09:00 ET
|
Activx Biosciences, Inc.
LA JOLLA, CA--(Marketwired - Oct 20, 2016) - ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces two reports published in high profile,...
Going KiNativ(TM): ActivX Publishes Landmark Article on Kinase Profiling
July 06, 2011 06:00 ET
|
Activx Biosciences, Inc.
LA JOLLA, CA--(Marketwire - Jul 6, 2011) - ActivX Biosciences, Inc. announced today the publication of "In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases" in the...
Activx Biosciences Head Receives Distinguished Scientist Award
January 04, 2010 09:00 ET
|
Activx Biosciences, Inc.
LA JOLLA, CA--(Marketwire - January 4, 2010) - Dr. John W. Kozarich, Chairman & President of
Activx Biosciences, Inc. (La Jolla, CA), has received the 2009
Distinguished Scientist Award from the...
Activx Biosciences, Inc. Announces Positive Phase Ib and IIa Clinical Trial Results for KRP-104, a Flexible Dosing DPP-4 Inhibitor for Type 2 Diabetes
August 21, 2008 06:00 ET
|
Activx Biosciences, Inc.
LA JOLLA, CA--(Marketwire - August 21, 2008) - Activx Biosciences, Inc., a wholly owned
subsidiary of Tokyo-based Kyorin Pharmaceutical Co., Ltd., announced today
topline results from their Phase Ib...